|
US6235884B1
|
|
Heparin binding mitogen with homology to epidermal growth factor (EGF)
|
|
US5530157A
|
|
Anti-inflammatory benzoic acid derivatives
|
|
CA2171446A1
|
|
Pseudo- and non-peptide bradykinin receptor antagonists
|
|
US5541286A
|
|
Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids
|
|
WO9419372A1
|
|
Cyclic bradykinin antagonist peptides
|
|
US5430020A
|
|
Recombinant alveolar surfactant protein
|
|
US5331095A
|
|
Process for purification of basic fibroblast growth factor
|
|
IL104043D0
|
|
Fluorenyl derivatives and pharmaceutical compositions containing them
|
|
US5472973A
|
|
Fluorenyl derivatives as anti-inflammatory agents
|
|
US5521158A
|
|
Pseudopeptide bradykinin receptor antagonists
|
|
US5256814A
|
|
Excitatory amino acid antagonists
|
|
US5258368A
|
|
Atrial natriuretic/vasodilator peptide compounds
|
|
ZA9202881B
|
|
Bradykinin type peptides
|
|
ZA9202880B
|
|
Bradykinin antagonist peptides
|
|
US5264550A
|
|
Human anti-inflammatory phospholipase inhibitor protein
|
|
CA2106762A1
|
|
Bradykinin Antagonist Peptides
|
|
EP0618809A4
|
|
Bradykinin type peptides
|
|
US5250537A
|
|
5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indole,-6,7,8,9,10-hexahydro-7,11-imino-5H-cyclooct[b]indole and substituted derivatives
|
|
US5221607A
|
|
Assays and reagents for amyloid deposition
|
|
US5387742A
|
|
Transgenic mice displaying the amyloid-forming pathology of alzheimer's disease
|
